Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: Acadia - You Need To See This

ACADIA Pharmaceuticals Spotlights Alzheimer’s Psychosis Pipeline, NUPLAZID and DAYBUE Growth

ACADIA Pharmaceuticals (NASDAQ:ACAD) executives used an RBC Capital Markets investor session to outline the company’s clinical rationale for remlifanserin in Alzheimer’s disease psychosis, provide updates on commercial trends for NUPLAZID and DAYBUE, and discuss selected pipeline and business develo

ACADIA Pharmaceuticals Targets $1B Brand Opportunity as Key Neuropsychiatry Data Looms

ACADIA Pharmaceuticals (NASDAQ:ACAD) executives said the company is focused on expanding its two commercial brands while preparing for several clinical data readouts in neuropsychiatric disorders, according to comments at the Bank of America Global Healthcare Conference. Chief Executive Officer Cat

The Importance of Acadia Healthcare's Partnerships With Healthcare Organizations

The Importance of Acadia Healthcare's Partnerships With Healthcare Organizations

Acadia Healthcare maintains equity partnerships with 21 healthcare systems that operate 22 behavioral health hospitals nationwide.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Activist Investors Are Betting Big on This 1 Buy-Rated Stock

ACHC stock is grabbing headlines as activist investors push for strategic shake-ups.

Activist Investor Builds 3% Stake In Acadia, Urges Board Refresh

Activist investor Engine Capital is pressuring Acadia Healthcare (NASDAQ:ACHC) to overhaul its board and rethink its growth strategy as the behavioral health provider grapples with federal investigations and steep share losses.

Acadia Pharma Faces Trial Setback As Prader-Willi Syndrome Trial Falls Short

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) released topline results on Wednesday from its Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin (ACP-101) in patients with hyperphagia in Prader-Willi syndrome (PWS).

Psych Hospital Operator Acadia Healthcare Downgraded As It Braces For Medicaid Cuts

Bank of America (BofA) Securities downgraded Acadia Healthcare Inc (NASDAQ:ACHC), a behavioral health company that operates inpatient psych hospitals, residential treatment centers, and outpatient clinics, as well as therapeutic school-based programs.

inkl

Read news from The Economist, FT, and more,
with one subscription

“I used different gadgets to make the guitar sound different. I used a few hammers – I don’t recommend that”: How Yasmin Williams is redefining the people’s music with kitchen implements and acoustic guitar

“I used different gadgets to make the guitar sound different. I used a few hammers – I don’t recommend that”: How Yasmin Williams is redefining the people’s music with kitchen implements and acoustic guitar

The acoustic folk virtuoso even used a frother from her parents’ kitchen to get a tone on new album Acadia, but, she tells us, the end justifies the means

3 Hidden Bargains in the Healthcare Sector

3 Hidden Bargains in the Healthcare Sector

Healthcare’s resilience makes it a go-to sector during market volatility. With steady demand, innovation, and aging demographics driving growth, investors could consider investing in fundamentally sound stocks like Viatris (VTRS), Bausch + Lomb Corp. (BLCO), and ACADIA Pharmaceuticals (ACAD). With strong industry tailwinds and discounted valuations, these stocks could offer…

Yasmin Williams, folk’s fantastical fingerpicker: ‘Guitar Hero shaped my experimental approach’

Yasmin Williams, folk’s fantastical fingerpicker: ‘Guitar Hero shaped my experimental approach’

After shredding on a video game axe during her teens, the American musician graduated to the real thing. She explains how her music chooses hope during dark times

The Guardian - UK

3 Pharma Stocks to Buy for Potential Financial Fortunes

3 Pharma Stocks to Buy for Potential Financial Fortunes

Amid surging medicine demand and ongoing drug shortages, the pharmaceutical industry thrives, driving improved patient outcomes and promising growth opportunities for investors. So, it could be wise to invest in quality pharma stocks ACADIA Pharmaceuticals (ACAD), Neurocrine Biosciences (NBIX), and Supernus Pharmaceuticals (SUPN), which can help you fetch potential financial…

Martha Stewart designed a 'versatile' outdoor furniture range inspired by the beauty of her 1925 Carriage House

Martha Stewart designed a 'versatile' outdoor furniture range inspired by the beauty of her 1925 Carriage House

The entertaining icon just brought 'timeless' class to hosting season – these are our favorite pieces from her collection

Homes & Gardens

2024 GMC Acadia Debuts: Bigger Bod With 328 HP, 15-Inch Portrait Display

2024 GMC Acadia Debuts: Bigger Bod With 328 HP, 15-Inch Portrait Display

It's nearly a foot longer with 80 percent more cargo space, and it's available with Super Cruise for hands-free driving.

Watch Rocket Lab launch Earth-observing radar satellite

Watch Rocket Lab launch Earth-observing radar satellite

Rocket Lab plans to launch an Earth-observing radar satellite for the company Capella Space in the coming days, and you can watch the action live.

Get all your
news in one place.

100's of premium titles.
One news app.

Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga Before The Bell: Should Investors Worry About Tesla's China Sales, Gold Back In Focus, Nio Smartphone Could Soon Be A Reality Other Top Financial Stories Friday, August 5

CNBC International Airlines Prepare For Mayhem Of Summer Travel Season: Report

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours:

Analysts Try To See Beyond Acadia's Alzheimer's Disease Psychosis

HC Wainwright says that a negative AdCom vote on Acadia Pharmaceuticals Inc&#

Get all your
news in one place.

100's of premium titles.
One news app.

The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

HC Wainwright Sees Opportunity For Acadia's Alzheimer's Candidate

HC Wainwright says FDA's briefing document on ACADIA Pharmaceuticals Inc's (NASDAQ: ACAD) pimavanserin was not unexpected.

Why ACADIA Pharmaceuticals Shares Are Trading Higher Today?

Ahead of Acadia Pharmaceuticals Inc's (NASDAQ:ACAD) FDA AdComm meeting on Friday, the agency officials released their briefing documents, revealing a mixed bag of opinions. The company's resubmitted supplemental New Drug Application for pimavanserin for hallucinations and delusions associated with Alzheimer's disease psychosis (ADP) has a target action date of August 4. Initially, the FDA…

The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs

Here's a roundup of top developments in the biotech space over the last 24 hours.

Why Acadia Pharma Shares Are Falling Today

Acadia Pharmaceuticals Inc (NASDAQ: ACAD) announced topline results from a Phase 2 trial evaluating the efficacy and safety of ACP-044 for acute pain following bunionectomy surgery.

Tribune News Service

Chicago keeps losing is Michelin-starred restaurants

When Michelin started awarding stars to Chicago restaurants in 2011, the city was one of the most exciting places to eat in America. Grant Achatz had recently opened his evolving restaurant concept, Next, and chefs like Laurent Gras and Graham Elliot were cooking wildly ambitious dishes. It was the country’s…

The Independent UK

As guest workers increase, so do concerns of wage cheating

From 2005 to 2020, U.S. employers around the country were ordered to pay more than $42.5 million in back wages to 69,000 workers who perform seasonal low-wage jobs on guest worker visas

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

European Commission

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Alzheimer Disease

Places

399,142 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play